Aura Biosciences (AURA) Change in Acquisitions & Divestments (2022 - 2026)

Aura Biosciences has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $55.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 83.33% year-over-year to $55.0 million; the trailing twelve-month figure through Mar 2026 stood at $145.0 million (down 8.91% YoY), and the FY2025 full-year result was $120.0 million, down 7.11% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $55.0 million, up from $30.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $99.2 million in Q3 2024, with the low at $18.0 million in Q3 2022.
• Historically, Change in Acquisitions & Divestments has averaged $36.5 million across 5 years, with a median of $30.0 million in 2025.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments surged 356.66% — and 2025, when it sank 69.75%.
• Aura Biosciences' Change in Acquisitions & Divestments stood at $32.0 million in 2022, then soared by 71.83% to $55.0 million in 2023, then tumbled by 45.46% to $30.0 million in 2024, then increased by 0.0% to $30.0 million in 2025, then surged by 83.33% to $55.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $55.0 million (Q1 2026), $30.0 million (Q4 2025), and $30.0 million (Q3 2025), per Business Quant data.